# Faı̈ez Zannad

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/fa-ez-zannad/

## Facts

| Field | Value |
| --- | --- |
| Citations | 171,044 |
| Field | Heart Failure Treatment and Management |
| h-index | 150 |
| i10-index | 931 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5036821495 |
| ORCID iD | 0000-0001-7456-1570 |
| Works | 1,549 |

## Researcher papers

Showing 12 of 84.

- [2013 ESH/ESC Guidelines for the management of arterial hypertension](https://scholariq.org/papers/2013-esh-esc-guidelines-for-the-management-of-arterial-hypertension/)
- [The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure](https://scholariq.org/papers/the-effect-of-spironolactone-on-morbidity-and-mortality-in-patients-with-severe/)
- [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-2/)
- [2013 ESH/ESC Guidelines for the management of arterial hypertension](https://scholariq.org/papers/2013-esh-esc-guidelines-for-the-management-of-arterial-hypertension-2/)
- [Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure](https://scholariq.org/papers/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/)
- [Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction](https://scholariq.org/papers/eplerenone-a-selective-aldosterone-blocker-in-patients-with-left-ventricular/)
- [Empagliflozin in Heart Failure with a Preserved Ejection Fraction](https://scholariq.org/papers/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/)
- [ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-3/)
- [Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms](https://scholariq.org/papers/eplerenone-in-patients-with-systolic-heart-failure-and-mild-symptoms/)
- [The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure](https://scholariq.org/papers/the-effect-of-spironolactone-on-morbidity-and-mortality-in-patients-with-severe-2/)
- [ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-4/)
- [2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension](https://scholariq.org/papers/2003-european-society-of-hypertension-european-society-of-cardiology-guidelines/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.